Home › NDC Lookup › RxCUI directory › RxCUI 1659814

Aripiprazole 400 MG Injection [Abilify] — RxCUI 1659814

Name: Aripiprazole 400 MG Injection [Abilify] (RxCUI 1659814)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1659814 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1659814

Official nameAripiprazole 400 MG Injection [Abilify]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asAbilify 400 MG Injection; Abilify Maintena 400 MG Extended Release Injection; Abilify Maintena 400 MG Injection

FDA products mapped4

Package NDCs mapped5

Reported Medicaid activity (SDUD)290,918 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aripiprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Not at all — aripiprazole actually has several approved uses. It's prescribed for schizophrenia, manic or mixed episodes of Bipolar I Disorder, and as an add-on to antidepressants...
What exactly is aripiprazole used for — is it just for schizophrenia?
It typically takes up to two weeks for aripiprazole to build up to stable levels in your body, so don't be discouraged if you don't feel a difference right away. For some condition...
How long does it take before I notice it working?

📖 Read our full Aripiprazole guide →

🕸️ Concept Web — How Aripiprazole 400 MG Injection [Abilify] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Aripiprazole 400 MG Injection [Abilify] RxCUI 1659814 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Aripiprazole 89013 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Abilify 352393 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Aripiprazole Injection 1659782 SCDF
- Aripiprazole Injectable Product 1158259 SCDG
- Aripiprazole Injection [Abilify] 1659784 SBDF
- Abilify Injectable Product 1165947 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Aripiprazole 400 MG Injection 1659812 SCD
- Aripiprazole 400 MG 1659811 SCDC
- Aripiprazole 400 MG [Abilify] 1659813 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Aripiprazole 400 MG Injection SCD · 1659812
Aripiprazole 400 MG SCDC · 1659811
Aripiprazole Injection SCDF · 1659782
Aripiprazole Injectable Product SCDG · 1158259

Brand-Name Concepts

Aripiprazole 400 MG [Abilify] SBDC · 1659813
Aripiprazole Injection [Abilify] SBDF · 1659784
Abilify Injectable Product SBDG · 1165947
Abilify BN · 352393

📦 FDA Products & Package NDCs

4 products · 5 package NDCs

5 package NDCs map to RxCUI 1659814 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
59148-0045-80	1 KIT in 1 CARTON (59148-045-80) * 1.5 mL in 1 SYRINGE *...	ABILIFY MAINTENA	Otsuka America Pharmaceutical, Inc.	2014-10-08
59148-0072-80	1 KIT in 1 CARTON (59148-072-80) * 1.9 mL in 1 SYRINGE *...	ABILIFY MAINTENA	Otsuka America Pharmaceutical, Inc.	2014-10-08
59148-0072-92	1 KIT in 1 CARTON (59148-072-92) * 1.9 mL in 1 SYRINGE *...	ABILIFY MAINTENA	Otsuka America Pharmaceutical, Inc.	2014-10-08
59148-0232-12	1 KIT in 1 CARTON (59148-232-12) * 1.5 mL in 1 VIAL, SINGL...	ABILIFY MAINTENA	Otsuka America Pharmaceutical, Inc.	2025-02-28
59148-0245-12	1 KIT in 1 CARTON (59148-245-12) * 1.9 mL in 1 VIAL, SINGL...	ABILIFY MAINTENA	Otsuka America Pharmaceutical, Inc.	2025-02-28

Observed labelers: Otsuka America Pharmaceutical, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0401	Inj, abilify maintena, 1 mg	4	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.